Publication | Closed Access

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial

ThrombosisVenous ThrombosisCardiovascular DiseaseAnticoagulant EffectHealthy Male VolunteersHematologyPharmacologyPharmacotherapyMedicineAnticoagulantDouble-blind Phase 1